Ep 196 - CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device

DeviceTalks Weekly

Jun 21 2024 | 00:48:11

00:00 / 00:48:11

Episode 196 • June 21, 2024 • 00:48:11

Hosted By

Show Notes

In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle. Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

Ep 98 - Think you know what Penumbra may look like in five years? CEO Elsesser’s vision might surprise

In this episode, Penumbra CEO Adam Elsesser shares why he left a successful law career to become CEO of a medical device startup. After...

Play

00:53:06

Ep 231 - Lotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCs

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a...

Play

01:04:58

Ep 134 - Hear about Dexcom's evolving mission statement and Medtronic's Cranial and Spinal Technologies plans

In this week’s episode, CEO Kevin Sayer takes a few minutes to share Dexcom’s vision for the future OUTSIDE of diabetes. What does this...

Play

01:15:18

Show Notes

Other Episodes

Ep 98 - Think you know what Penumbra may look like in five years? CEO Elsesser’s vision might surprise

Ep 231 - Lotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCs

Ep 134 - Hear about Dexcom's evolving mission statement and Medtronic's Cranial and Spinal Technologies plans